Cargando…
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
The Coronavirus Disease 2019 (COVID-19) pandemic is still spreading worldwide over 2 years since its outbreak. The psychopathological implications in COVID-19 survivors such as depression, anxiety, and cognitive impairments are now recognized as primary symptoms of the “post-acute COVID-19 syndrome....
Autores principales: | Mazza, Mario Gennaro, Palladini, Mariagrazia, Poletti, Sara, Benedetti, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210800/ https://www.ncbi.nlm.nih.gov/pubmed/35727534 http://dx.doi.org/10.1007/s40263-022-00931-3 |
Ejemplares similares
-
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors
por: Poletti, Sara, et al.
Publicado: (2022) -
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression
por: Mazza, Mario Gennaro, et al.
Publicado: (2022) -
The Burden of Survivorship: Survivor Guilt and Its Association with Psychiatric Sequelae in COVID-19 Patients
por: Palladini, Mariagrazia, et al.
Publicado: (2023) -
Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life
por: Poletti, Sara, et al.
Publicado: (2021) -
Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)